BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹52 Cr | ₹54 Cr | ₹46 Cr | ₹22 Cr | ₹24 Cr |
What is the latest Total Current Liabilities ratio of BAFNA PHARMACEUTICALS ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹52 Cr |
Mar2024 | ₹54 Cr |
Mar2023 | ₹46 Cr |
Mar2022 | ₹22 Cr |
Mar2021 | ₹24 Cr |
How is Total Current Liabilities of BAFNA PHARMACEUTICALS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹52 Cr | -4.13 | |
Mar2024 | ₹54 Cr | 16.37 | |
Mar2023 | ₹46 Cr | 111.13 | |
Mar2022 | ₹22 Cr | -9.45 | |
Mar2021 | ₹24 Cr | - |
Compare Total Current Liabilities of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹325.5 Cr | 10.8% | 31.2% | 52.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | 10.8% |
31.2% |
52.2% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses